Endothelial cell-derived pro-fibrotic factors increase TGF-β1 expression by smooth muscle cells in response to cycles of hypoxia-hyperoxia.
Endothelial cell-derived pro-fibrotic factors increase TGF-β1 expression by smooth muscle cells in response to cycles of hypoxia-hyperoxia.
复制标题
DOI:
10.1016/j.bbadis.2021.166278
复制
发表时间:
2022-01-01
期刊:
影响因子:
--
通讯作者:
Koutakis P
中科院分区:
文献类型:
--
作者:
Ismaeel A;Miserlis D;Papoutsi E;Haynatzki G;Bohannon WT;Smith RS;Eidson JL;Casale GP;Pipinos II;Koutakis P
The vascular pathology of peripheral artery disease (PAD) encompasses abnormal microvascular architecture and fibrosis in response to ischemia-reperfusion (I/R) cycles. We aimed to investigate the mechanisms by which pathological changes in the microvasculature direct fibrosis in the context of I/R. Primary human aortic endothelial cells (ECs) were cultured under cycles of normoxia-hypoxia (NH) or normoxia-hypoxia-hyperoxia (NHH) to mimic I/R. Primary human aortic smooth muscle cells (SMCs) were cultured and treated with media from the ECs. The mRNA and protein expression of the pro-fibrotic factors platelet derived growth factor (PDGF)-BB and connective tissue growth factor (CTGF) were significantly upregulated in ECs undergoing NH or NHH cycles. Treatment of SMCs with media from ECs undergoing NH or NHH cycles led to significant increases in TGF-β1, TGF-β pathway signaling intermediates, and collagen expression. Addition of neutralizing antibodies against PDGF-BB and CTGF to the media blunted the increases in TGF-β1 and collagen expression. Treatment of SMCs with PAD patient-derived serum also led to increased TGF-β1 levels. In an in-vitro model of I/R, which recapitulates the pathophysiology of PAD, increased secretion of PDGF-BB and CTGF by ECs was shown to be predominantly driving TGF-β1-mediated expression by SMCs. These cell culture experiments help elucidate the mechanism and interaction between ECs and SMCs in microvascular fibrosis associated with I/R. Thus, targeting these pro-fibrotic factors may be an effective strategy to combat fibrosis in response to cycles of I/R. National Institute on Aging at the National Institutes of Health grant number R01AG064420.
登录
查看更多内容
DOI:
10.3390/antiox7100145
发表时间:
2018-10-19
期刊:
Antioxidants (Basel, Switzerland)
影响因子:
--
作者:
Ismaeel A;Brumberg RS;Kirk JS;Papoutsi E;Farmer PJ;Bohannon WT;Smith RS;Eidson JL;Sawicki I;Koutakis P
通讯作者:
Koutakis P
影响因子:
3.4
作者:
Ge X;Chen SY;Liu M;Liang TM;Liu C
通讯作者:
Liu C
DOI:
10.1083/jcb.114.6.1285
发表时间:
1991-09
期刊:
The Journal of cell biology
影响因子:
--
作者:
Bradham DM;Igarashi A;Potter RL;Grotendorst GR
通讯作者:
Grotendorst GR
影响因子:
64.8
作者:
Chouchani, Edward T.;Pell, Victoria R.;Gaude, Edoardo;Aksentijevic, Dunja;Sundier, Stephanie Y.;Robb, Ellen L.;Logan, Angela;Nadtochiy, Sergiy M.;Ord, Emily N. J.;Smith, Anthony C.;Eyassu, Filmon;Shirley, Rachel;Hu, Chou-Hui;Dare, Anna J.;James, Andrew M.;Rogatti, Sebastian;Hartley, Richard C.;Eaton, Simon;Costa, Ana S. H.;Brookes, Paul S.;Davidson, Sean M.;Duchen, Michael R.;Saeb-Parsy, Kourosh;Shattock, Michael J.;Robinson, Alan J.;Work, Lorraine M.;Frezza, Christian;Krieg, Thomas;Murphy, Michael P.
通讯作者:
Murphy, Michael P.
影响因子:
4.3
作者:
Dardik, A;Yamashita, A;Sumpio, BE
通讯作者:
Sumpio, BE